117678-37-2 Usage
General Description
Levofloxacin N-oxide is a derivative of the antibiotic levofloxacin that is formed in the body through the process of oxidation. Levofloxacin is a broad-spectrum antibiotic that is used to treat a variety of bacterial infections, and its N-oxide derivative has been found to have similar antimicrobial activity. Levofloxacin N-oxide has been studied for its potential as a novel antimicrobial agent and has shown promising results in inhibiting the growth of bacteria, including drug-resistant strains. Additionally, research has indicated that the N-oxide derivative may also have lower potential for causing antibiotic resistance compared to the parent compound. Further investigation into the therapeutic potential of levofloxacin N-oxide is ongoing, with potential applications in the development of new antibiotics for the treatment of bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 117678-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,6,7 and 8 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 117678-37:
(8*1)+(7*1)+(6*7)+(5*6)+(4*7)+(3*8)+(2*3)+(1*7)=152
152 % 10 = 2
So 117678-37-2 is a valid CAS Registry Number.
117678-37-2Relevant articles and documents
N-oxides as antibacterial agents
-
, (2008/06/13)
PCT No. PCT/EP96/02171 Sec. 371 Date Nov. 19, 1997 Sec. 102(e) Date Nov. 19, 1997 PCT Filed May 20, 1996 PCT Pub. No. WO96/38417 PCT Pub. Date Dec. 5, 1996The present invention relates to new antibacterial compositions, in particular orally administrable compositions, based on N-oxides of saturated nitrogen-containing heterocycles which are substituted by quinolonecarboxylic acids or naphthyridonecarboxylic acids, and to new active compounds and their preparation.
